Kenyan Health Patient Information Leaflet
Non-opioid analgesic / antipyretic
Pain especially that of the neck and shoulder due to neuromuscular and skeletal spasm Clinical selection for Paracetamol/ Thiocolchicoside should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Non-opioid analgesic / antipyretic. Confirm site-specific dose, duration and monitoring before prescribing.
Dosing is indication-, age-, weight- and organ-function-specific for this INN. Do not use class averages for high-risk patients. Confirm the exact regimen in the current SmPC and Kenya Standard Treatment Guidelines. Typical professional workflow: (1) confirm indication, (2) check renal/hepatic function, (3) screen interactions/allergies, (4) select dose/route/duration, (5) define monitoring.
[Paracetamol] Rare at therapeutic doses. Serious: acute liver failure in overdose, rare severe skin reactions (SJS/TEN/AGEP). [Thiocolchicoside] Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Store as labelled. Keep out of reach of children.